Skip to main content
VREX
NASDAQ Manufacturing

Varex Reports Strong Q1 FY26 Results, Exceeding Guidance with 5% Revenue Growth

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$14.08
Mkt Cap
$593.16M
52W Low
$6.76
52W High
$14.565
52W Position info
108% above low
Off High info
3.3% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

VREX has more than doubled off its 52-week low of $6.76.

Summary

Varex Imaging Corporation announced solid first-quarter fiscal year 2026 results, with revenues up 5% year-over-year and non-GAAP diluted EPS nearly doubling, meeting the high end of guidance.


Key Events · Earnings and Guidance · VREX

  • Q1 FY26 Financial Performance

    Reported revenues of $210 million, a 5% year-over-year increase, with non-GAAP diluted EPS of $0.19, nearly doubling from $0.10 in the prior year.

  • Guidance Exceeded

    Q1 results were at the high end of the company's guidance, indicating strong operational execution.

  • Industrial Segment Growth

    The Industrial segment revenue grew 17% year-over-year, primarily driven by strength in cargo systems.

  • Updated Non-GAAP Policy

    The company modified its non-GAAP policy to exclude gains and losses from equity-method investments, aiming to provide a clearer view of ongoing operations.


Analysis · VREX · Manufacturing

Varex Imaging Corporation delivered a solid start to fiscal year 2026, reporting revenues of $210 million, a 5% increase year-over-year, driven by robust performance in its Industrial segment. Non-GAAP diluted EPS significantly improved to $0.19 from $0.10 in the prior year, indicating improved profitability. While the company experienced a cash outflow from operations due to increased working capital, the overall financial performance met the high end of guidance. The updated non-GAAP policy, which now excludes equity-method investment gains/losses, provides a clearer view of core operational performance. The positive Q2 FY26 revenue and EPS guidance suggests continued momentum, aligning with the stock trading near its 52-week high.

How filings like this one have moved

In the 30 days to Sep 12, 2026, 29.5% of the 1882 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.18%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VREX was trading at $14.08 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $593.2M. The 52-week trading range was $6.76 to $14.57. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREX - Latest Insights

VREX
Sep 08, 2026, 5:19 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $18.36
Real-time Price: $18.46 info
Change: +$0.100 (+0.54%) info
Market Cap: $778.057M info
VREX
Aug 10, 2026, 4:51 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $18.47
Real-time Price: $18.46 info
Change: -$0.0100 (-0.05%) info
Market Cap: $778.057M info
VREX
Aug 10, 2026, 4:07 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $18.45
Real-time Price: $18.46 info
Change: +$0.010 (+0.05%) info
Market Cap: $778.057M info
VREX
Aug 10, 2026, 7:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.57
Real-time Price: $18.46 info
Change: -$0.1055 (-0.57%) info
Market Cap: $778.057M info
VREX
May 07, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.29
Real-time Price: $18.46 info
Change: +$7.17 (+63%) info
Market Cap: $778.057M info